EUS-guided biliary drainage (EUS-BD) has been developed for failed or difficult ERCP. In particular, EUS-guided antegrade stenting (EUS-AGS) combined with EUS-guided hepaticogastrostomy (EUS-HGS) is suitable for gastric outlet obstruction (GOO) or surgically altered anatomy. [1] However, EUS-BD requires fistula dilation before stenting and carries the potential risk of bile leak from the fistula. Herein, we present the case of a patient who underwent EUS-HGS combined with EUS-AGS for unresectable duodenal cancer, using novel ultra-slim devices.
A 78-year-old woman presented with a 1-week history of vomiting and obstructive jaundice. Esophagogastroduodenoscopy revealed advanced duodenal cancer and GOO [ Figure 1a ]. Contrast-enhanced computed tomography showed distal bile duct obstruction caused by the duodenal cancer [ Figure 1b ]. We performed EUS-AGS combined with EUS-HGS for BD. First, a B 3 branch was punctured using a 19G needle, and a 0.025" stiff guidewire (VisiGlide 2, Olympus Inc. Tokyo, Japan) was placed [Video 1]. Next, a tapered ERCP catheter was used to dilate the fistula following successful passage of the guidewire through the distal bile duct stricture. Then, EUS-AGS was performed using a novel ultra-slim uncovered self-expandable metal stent (ZEOSTENT V; 5.4-Fr delivery system, 10-mm diameter; Zeon Medical Inc. Tokyo, Japan) [ Figure 2a and b]. Finally, a novel 7-Fr plastic stent (TYPE-IT stent; Gadelius Medical Co. Ltd., Tokyo, Japan) [Video 1] was placed to create an EUS-HGS without any complications [ Figure 2c and Video 1].
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Video Available on: www.eusjournal.com and reducing device exchanges. Ultra-slim devices (7-Fr or less) are suitable as they can facilitate the procedure. [1, 2] Ultra-slim devices also allow for relatively easy stent deployment with less frequent microdamage to the echoendoscope. Although a consensus cannot be reached in EUS-BD, EUS-AGS combined with EUS-HGS using ultra-slim devices is safe. Thus, the development of uncovered metallic stents with ultra-slim delivery is a key for successful procedure.
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